COMP <GO>
AEHR vs CEG // REVENUE GROWTH (YOY)
Aehr Test Systems (NASDAQ) VS. Constellation Energy Corporation Common Stock (NASDAQ) • 15-METRIC TALLY: AEHR 4
— CEG 10
▲ REVENUE GROWTH (YOY) LEADER: CEG
LAST: $54.89 (-10.33%) • MKT CAP: $2.00B
revenue-growth
-15.20%
LAST: $262.38 (-0.83%) • MKT CAP: $93.74B
revenue-growth
19.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AEHR VS. CEG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AEHR | CEG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.30% | 41.00% | -5.70 | CEG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.00% | 13.40% | -20.40 | CEG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 17.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.27% | 1.37% | -1.64 | CEG | /fcf-yield <GO> |
| Operating Margin | -28.30% | 13.60% | -41.90 | CEG | /operating-margins <GO> |
| Net Profit Margin | -14.30% | 10.20% | -24.50 | CEG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -15.20% | 19.50% | -34.70 | CEG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 0.52% | +2.88 | AEHR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 2.13 | +23.87 | AEHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | CEG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.10% | 5.90% | +0.20 | CEG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.5 | 46.6 | -14.12 | CEG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.76 | 0.71 | +0.05 | AEHR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 33.9x | -0.90 | AEHR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.00B | $93.74B | -$91.74B | CEG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AEHR REV | CEG REV | AEHR GROSS % | CEG GROSS % | AEHR FCF | CEG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $50.0M | $22.66B | 35.3% | 44.0% | -$5.4M | $1.29B |
| FY 2024 | $59.0M | $18.96B | 40.6% | 44.0% | -$12.4M | -$5.03B |
| FY 2023 | $66.2M | $20.84B | 44.0% | 44.0% | -$1.2M | -$6.24B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AEHR // BETA 0.76
CEG // BETA 0.71